The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks

By The Online Investor Staff, updated Fri., Sep. 30, 9:24 AM

#15 of the Dow 30: Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of a range of products in the health care field. Co. is organized into three business segments: Consumer, which is include a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. Pharmaceutical, which is focused on five therapeutic areas: immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. Medical Devices, which is include products used in the orthopaedic, surgery, cardiovascular, diabetes care and vision care fields.

Johnson and Johnson SEC Filing Email Alerts Service

Open the JNJ Page at The Online Investor »

Company Name:  Johnson & Johnson
Stock buyback:  JNJ buyback
Website:  www.jnj.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding JNJ:  115
Total Market Value Held by ETFs:  $12.14B
Total Market Capitalization:  $326.17B
% of Market Cap. Held by ETFs:  3.72%

Open the JNJ Page at The Online Investor (in a new window) »

September 30, 2016    9:24 AM Eastern

Buy (2.89 out of 4)
40th percentile
(ranked lower than approx. 60% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite
Quotes delayed 20 minutes



Buy (2.89 out of 4)
40th percentile
(ranked lower than approx. 60% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks - Slide 1 of 15 | www.TheOnlineInvestor.com | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.